List of Excipients in API aspirin and omeprazole
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing aspirin and omeprazole
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Genus Lifesciences Inc | YOSPRALA | aspirin and omeprazole | 64950-424 | CARNAUBA WAX | 2033-01-02 |
| Genus Lifesciences Inc | YOSPRALA | aspirin and omeprazole | 64950-424 | CELLULOSE, MICROCRYSTALLINE | 2033-01-02 |
| Genus Lifesciences Inc | YOSPRALA | aspirin and omeprazole | 64950-424 | FD&C BLUE NO. 2 | 2033-01-02 |
| Genus Lifesciences Inc | YOSPRALA | aspirin and omeprazole | 64950-424 | FERRIC OXIDE YELLOW | 2033-01-02 |
| Genus Lifesciences Inc | YOSPRALA | aspirin and omeprazole | 64950-424 | GLYCERYL MONOSTEARATE | 2033-01-02 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for aspirin and omeprazole
Excipient focus: CARNAUBA WAX
aspirin and omeprazole drug variants containing CARNAUBA WAX
aspirin and omeprazole drug variants not containing CARNAUBA WAX
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
aspirin and omeprazole drug variants containing CELLULOSE, MICROCRYSTALLINE
aspirin and omeprazole drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
aspirin and omeprazole drug variants containing FD&C BLUE NO. 2
aspirin and omeprazole drug variants not containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
aspirin and omeprazole drug variants containing FERRIC OXIDE YELLOW
aspirin and omeprazole drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERYL MONOSTEARATE
aspirin and omeprazole drug variants containing GLYCERYL MONOSTEARATE
aspirin and omeprazole drug variants not containing GLYCERYL MONOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
aspirin and omeprazole drug variants containing HYPROMELLOSE
aspirin and omeprazole drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Aralez Pharmaceuticals Us Inc | aspirin and omeprazole | 70347-081 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
aspirin and omeprazole drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Aralez Pharmaceuticals Us Inc | aspirin and omeprazole | 70347-081 |
| >Company | >Ingredient | >NDC |
aspirin and omeprazole drug variants not containing HYPROMELLOSES
Excipient focus: METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
aspirin and omeprazole drug variants containing METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
aspirin and omeprazole drug variants not containing METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Genus Lifesciences Inc | aspirin and omeprazole | 64950-424 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
aspirin and omeprazole drug variants containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Genus Lifesciences Inc | aspirin and omeprazole | 64950-424 |
| >Company | >Ingredient | >NDC |
aspirin and omeprazole drug variants not containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
Excipient focus: POLYDEXTROSE
aspirin and omeprazole drug variants containing POLYDEXTROSE
aspirin and omeprazole drug variants not containing POLYDEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
aspirin and omeprazole drug variants containing POLYETHYLENE GLYCOL
aspirin and omeprazole drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Aralez Pharmaceuticals Us Inc | aspirin and omeprazole | 70347-081 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOLS
aspirin and omeprazole drug variants containing POLYETHYLENE GLYCOLS
| Company | Ingredient | NDC |
|---|---|---|
| Aralez Pharmaceuticals Us Inc | aspirin and omeprazole | 70347-081 |
| >Company | >Ingredient | >NDC |
aspirin and omeprazole drug variants not containing POLYETHYLENE GLYCOLS
Excipient focus: POLYSORBATE 80
aspirin and omeprazole drug variants containing POLYSORBATE 80
aspirin and omeprazole drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
aspirin and omeprazole drug variants containing POVIDONE
aspirin and omeprazole drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
aspirin and omeprazole drug variants containing SILICON DIOXIDE
aspirin and omeprazole drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
aspirin and omeprazole drug variants containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
aspirin and omeprazole drug variants not containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
aspirin and omeprazole drug variants containing STARCH, CORN
aspirin and omeprazole drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: STEARIC ACID
aspirin and omeprazole drug variants containing STEARIC ACID
aspirin and omeprazole drug variants not containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
aspirin and omeprazole drug variants containing TALC
aspirin and omeprazole drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
aspirin and omeprazole drug variants containing TITANIUM DIOXIDE
aspirin and omeprazole drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
aspirin and omeprazole drug variants containing TRIACETIN
aspirin and omeprazole drug variants not containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRIETHYL CITRATE
aspirin and omeprazole drug variants containing TRIETHYL CITRATE
aspirin and omeprazole drug variants not containing TRIETHYL CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
